FISHERS, IN & MALVERN, PA — LSOMS Holdings, L.P., a portfolio company of 3 Boomerang Capital, LP (3BC), has announced its acquisition of Pinnaql, Inc., a leading provider of laboratory validation and global GxP compliance services for the pharmaceutical, biotech, and medical device industries. The move marks LSOMS Holdings’ first acquisition as it sets out to establish a premier quality and regulatory consulting platform dedicated to navigating the complexities of life sciences compliance.
Founded in 2019 and headquartered in Malvern, Pennsylvania, Pinnaql specializes in ensuring regulatory and operational readiness for laboratory environments. The company has built a reputation for excellence in quality standards and lab instrument validation, particularly in highly regulated biopharmaceutical markets.
“Pinnaql’s focus on technical excellence and exceptional client service fits seamlessly with the values that drove us to build the initial platform,” said John Duffin, Chief Executive Officer of LSOMS Holdings. “By partnering with Pinnaql, we gain immediate scale in laboratory instrument lifecycle management and validation with leading pharmaceutical companies that our experts have served for years. This acquisition complements our existing engineering and consulting services, enabling us to better support clients through the complex drug and medical device product lifecycles.”
The acquisition strengthens LSOMS’s core competencies in compliance and validation services, key areas for life sciences organizations facing increasingly intricate regulatory frameworks. By leveraging the Pinnaql brand, LSOMS aims to scale its offerings and position itself as a leading player in the life sciences consulting landscape.
Peter Wen, Principal at 3 Boomerang Capital, emphasized the strategic importance of the deal. “3BC is excited about adding Pinnaql to the LSOMS platform and believes that the acquisition will elevate LSOMS’s compliance function and broaden the team’s validation services talent pool within high-growth end markets,” Wen said. “We continue to seek out partners to strengthen our offering for life sciences companies.”
This acquisition represents the first step in LSOMS’s broader strategy to establish a robust and differentiated consulting platform that serves innovators across the pharmaceutical, biotech, and medical device sectors.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.